Organigram Holdings Inc. (OGI.TO)
| Previous Close | 2.5800 |
| Open | 2.5700 |
| Bid | 2.5600 x N/A |
| Ask | 2.5700 x N/A |
| Day's Range | 2.5600 - 2.7200 |
| 52 Week Range | 1.3500 - 3.9500 |
| Volume | |
| Avg. Volume | 208,104 |
| Market Cap | 278.49M |
| Beta (5Y Monthly) | 1.13 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.5100 |
| Earnings Date | Dec 17, 2024 - Dec 23, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 3.72 |
- Market Exclusive
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Key Takeaways; Cannabis Sector Organigram secured CA$41.5 million in second investment tranche from British American Tobacco. Jushi Holdings filed for CA$350 million shelf offering. Massachusetts social equity advocates are demanding investigation into Ascend Wellness over cannabis license violations. Key Takeaways; Psychedelic Sector Awakn filed new patent for ‘promising’ psychedelic compounds to treat PTSD. GH Research […]
Business WireOrganigram Closes Second Tranche of Previously Announced BAT Private Placement Investment
TORONTO, September 03, 2024--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, announced today that on August 30, 2024, the Company closed the second of three tranches (the "Second Tranche") of the previously announced C$124,559,674 follow-on strategic equity investment (the "Investment") by BT DE Investments Inc. (the "Investor"), a wholly owned subsidiary of British American Tobacco plc ("BAT"). Pursuant to the Second T
- Associated Press Finance
OrganiGram: Fiscal Q3 Earnings Snapshot
TORONTO (AP) — OrganiGram Holdings Inc. OGI) on Tuesday reported fiscal third-quarter earnings of $2.1 million. On a per-share basis, the Toronto-based company said it had net income of 2 cents.
